Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of XM17 vs Gonal-f in Healthy Women
NCT02592031Phase 1Completed
- Sponsor
- Merckle GmbH
- Start
- Feb 2009
- Primary completion
- May 2009
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised, open-label trial of follitropin alfa in infertility (2 arms), sponsored by Merckle GmbH. Primary endpoints: Maximum Serum Concentration at 168 hours and Area Under the Curve from time 0 to last measurable concentration at 168 hours. Started Feb 2009; status: completed.
02
Drugs
follitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02592031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02592031.